HTA251 Unraveling the Relationship between Expedited Regulatory Approval By the European Medicines Agency (EMA) and Reimbursement Outcomes for Drugs Approved Under Exceptional Circumstances
Abstract
Authors
A. Guyenet P. Berto C. Chamoux L. Crathorne G. Outteridge C. Roeder